Business Wire

The AGENCY for Virtual Reality for Vodafone Teams up with Amimon to Bring an Ultra-Low Latency Hyper Reality Experience “VR Dome” at CEBIT 2018

Jaa

Amimon (http://www.amimon.com/), the creators of wireless HD Joint-Source-Channel-Coding (JSCC) technology, and The Agency for Virtual Reality (A4VR) (www.a4vr.com), the international leading agency and pioneer in VR, are partnering to create the journey 4.0 for Vodafone with “VR Dome” at CEBIT 2018 that will take visitors on a thrilling 7 minute time travel throughout history.

The “VR Dome” is a new dimension of Hyper-Reality-Experience, combining the most innovative VR-technologies, interactive storytelling and a mixture of fiction and reality creating new worlds. In small groups and virtual spacesuits, this multi-immersive journey takes you from the beginnings of industrial history to the present, and all the way to the moon in a space-shuttle. This virtually guided experience brings visitors performing actors, personalized faces and mulitsensoric impressions in combination with the newest generation of wireless connectivity. From the very first moment they step into the dome, each visitor can engage with all five senses, and interact with one another and with personalized avatars to experience magical moments.

The “VR Dome” utilizes Amimon’s patented wireless video system for transmitting UHD video with zero latency to provide a fully immersive experience in the virtual space. Amimon’s system supports multi-user scenarios, such as those used in large location-based VR. Amimon’s 3rd generation chipset supports VR resolution of 2K at 90 frames per second as required by the HTC Vive and Oculus Rift headsets, or up to 120 frames per seconds of FHD resolution used in Sony PSVR.

“Curiosity has always been deeply rooted in humans. The fusion of innovative technologies, real sensual experiences and emotional storytelling allows us to transition into new exciting worlds within seconds, visit peculiar destinations – bringing stories alive,” says Michael Albrecht and Jan Thiel, founders of A4VR. “Future visions become a reality, because only those who experience and feel it can envision it! We are making the impossible possible! The “VR Dome” combines this perfectly and shows how the wireless connectivity shapes new technical principles for real life experiences. With this campaign, A4VR is building on previous multi-immersive VR-projects like the autonomous, Vodafone Giga Car at CEBIT 2017.”

“To create a truly immersive virtual experience, it’s essential to mimic real life visual and sound effects without any lagging,” says Ram Ofir, CEO of Amimon. “Amimon’s zero latency wireless technology is able to provide a true untethered experience, while significantly reducing simulation sickness associated with low frame rate or image delay. With this unique collaboration, we’re able to bring our technology to VR Dome for audiences all over the world, to enjoy a breathtaking journey through time.”

The “VR Dome” will be exhibited at CEBIT 2018 at Vodafone’s booth in front of the pavilion #P33.

About Amimon

Wireless HD video connectivity is creating a revolution in content creation and consumption. AMIMON, a market leader in zero latency wireless HD video, has invented exclusive technology to harness the power of mobile cameras and fixed video sources, to bring HD content to remote display screens or distribution switches. AMIMON’s systems utilize its core technology to deliver convenience and flexibility to create, transmit and view content on remote devices with the highest image quality. AMIMON is headquartered in San Jose, California, with offices in Raanana Israel; Tokyo, Japan; and Taipei, Taiwan.

About A4VR – The AGENCY for Virtual Reality

The Agency for Virtual Reality is an international leading agency and pioneer in the field of virtual reality, based in Düsseldorf, Germany. Creating a unique combination of creative storytelling and virtual reality technologies with multi immersive components such as smells, temperatures, movements and real-world objects in the physical world. Hereby A4VR creates magical brand experiences for companies such as Vodafone, Coca-Cola, Pro. 7 and SOS Children’s Villages. The team of professional VR evangelists, content and real-time producers, creative project managers, digital strategists and live communications experts focuses on individual interdisciplinary 360 ° labs and successfully combines conception with development, production and realization. With the newest technical possibilities, the team brings together Realtime-VR-technology, Full-Body-Motion tracking, wireless content transfer, Motion platforms and a lot more: Creating a world within the world, blurring the boundaries between reality and fiction. The observers are being touched with all their senses so that they can open up to this out of the-ordinary and visionary experience. For more information: www.a4vr.com.

Contact information

Company Media Contact:
Ilit Gluska, +tel: 972-558895272 (cell)
Blonde 2.0 for Amimon
ilit@blonde20.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 14:00Tiedote

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 11:10Tiedote

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 18:13Tiedote

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 17:00Tiedote

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 16:41Tiedote

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 15:00Tiedote

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme